{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:59:33Z","timestamp":1768510773351,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/maj.0b013e318271f910","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T07:12:37Z","timestamp":1352445157000},"page":"283-288","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of Urinary Biomarkers for the Prognosis of Drug-associated Chronic Tubulointerstitial Nephritis"],"prefix":"10.1016","volume":"346","author":[{"given":"Yingjin","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1097\/MAJ.0b013e318271f910_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-1797.2010.01304.x","article-title":"Epidemiology, impact and preventive care of chronic kidney disease in Taiwan","volume":"15","author":"Hwang","year":"2010","journal-title":"Nephrology (Carlton)"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0010","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ndt\/gfr291","article-title":"Aristolochic acid nephropathy: variation in presentation and prognosis","volume":"27","author":"Yang","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0015","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1681\/ASN.2010080793","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"21","author":"Zeisberg","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0025","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","article-title":"Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition","volume":"282","author":"Zeisberg","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0030","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0035","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0045","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0272-6386(03)00023-4","article-title":"Validity of proteinosmolality versus protein-creatinine ratios in the estimation of quantitative proteinuria from random samples of urine in children","volume":"41","author":"Morgenstern","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0050","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1097\/01.ju.0000049201.91150.9d","article-title":"Matrix metalloproteinase activity in urine of patients with renal cell carcinoma leads to degradation of extracellular matrix proteins: possible use as a screening assay","volume":"169","author":"Sherief","year":"2003","journal-title":"J Urol"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0055","first-page":"425","article-title":"Literature on vertebrate matrix metalloproteinases and their tissue inhibitors","volume":"1","author":"Woessner","year":"1992","journal-title":"Matrix Suppl"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0060","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/bmj.3.5980.408","article-title":"Urinary N-acetyl-beta-Dglucosaminidase activities in patients with renal disease","volume":"3","author":"Wellwood","year":"1975","journal-title":"Br Med J"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/18.3.543","article-title":"Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit","volume":"18","author":"Westhuyzen","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0070","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.ajkd.2010.12.022","article-title":"Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients","volume":"57","author":"Nauta","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0075","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/ndt\/gfn007","article-title":"Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy","volume":"23","author":"Hofstra","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0080","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/ndt\/17.11.1890","article-title":"Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis","volume":"17","author":"Bazzi","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0085","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/MAJ.0b013e3181dd0cb1","article-title":"Urinary neutrophil gelatinase-associated lipocalin: a potential biomarker for predicting rapid progression of druginduced chronic tubulointerstitial nephritis","volume":"339","author":"Wu","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0090","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2215\/CJN.02370310","article-title":"Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis","volume":"5","author":"Wu","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1623","article-title":"Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical bio-marker qualification studies","volume":"28","author":"Vaidya","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0100","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1093\/ndt\/gfm300","article-title":"Urinary excretion of endothelin-1 (ET-1), transforming growth factor-beta1 (TGF-beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial","volume":"22","author":"Grenda","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0105","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/ajkd.2001.29209","article-title":"Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy","volume":"38","author":"Haramaki","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0110","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/ndt\/gfg090","article-title":"Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy","volume":"18","author":"Park","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.2011.224","article-title":"Oral cholecalciferol decreases albuminuria and urinary TGF-beta1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition","volume":"80","author":"Kim","year":"2011","journal-title":"Kidney Int"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1440-1797.2011.01459.x","article-title":"Urinary transforming growth factor-beta1 in children with obstructive uropathy","volume":"16","author":"Zieg","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0125","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/ndt\/17.12.2145","article-title":"Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria","volume":"17","author":"Goumenos","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.phrs.2003.10.003","article-title":"Urinary transforming growth factor-beta 1 in various types of nephropathy","volume":"49","author":"De Muro","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ndt\/gfl556","article-title":"Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis","volume":"22","author":"Yang","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0140","first-page":"213","article-title":"Roles of connective tissue growth factor (CTGF) in the fibrosis of Manchurian dutchmanspipe induced tubulo-interstitial nephropathy [in Chinese]","volume":"19","author":"Yang","year":"2003","journal-title":"Chin J Nephrol"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0145","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ndt\/17.7.1189","article-title":"Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis","volume":"17","author":"Urushihara","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0150","doi-asserted-by":"crossref","first-page":"F1927","DOI":"10.1152\/ajprenal.00310.2007","article-title":"Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis","volume":"293","author":"Sanders","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1097\/MAJ.0b013e318271f910_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2478\/v10042-008-0086-4","article-title":"Differential glomerular immunoexpression of matrix metalloproteinases MMP-2 and MMP-9 in idiopathic IgA nephropathy and Schoenlein-Henoch nephritis","volume":"48","author":"Danilewicz","year":"2010","journal-title":"Folia Histochem Cytobiol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915305140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915305140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T12:24:00Z","timestamp":1562329440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915305140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0002962915305140"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e318271f910","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}